Rheumnow Podcast

A Novel Treatment Response Measurement Tool for Lupus
ACR22 Year in Review Report
Breakthrough COVID infection in SLE during Omicron era
Effect of voclosporin in class V lupus nephritis
Lupus, Sex and STDs
Poor Medication Adherence in SLE and How to Improve It
Prelude to a Meeting (ACR22) (11.11.2022)
Should You Repeat the ENA Panel?
Urinary Biomarkers in Lupus
Urine Proteomics in SLE with Dr. Michelle Petri

Sunday (Day 2): ACR 22 Daily Recap

ACR 2022 Appraisal, Praise & Critique (11.18.2022)
Best of ACR Day Two in PSA
Efficacy and Safety Results from BE OPTIMAL in PsA
JAK inhibitors in rheumatic diseases
Oligoarticular PsA: FOREMOST Study
Opioid use in PsA and SpA
PET CT Imaging to Define Risk of Progression from PSO to PsA
PsA and SPA: Cyclers, Switchers, Who is the Winner?
Switch vs Cycle in PsA
Women vs. Men: Response to Treatment in Seronegative Arthritis

Best of PsA on Day 1
Can computers tell the difference between RA & PsA?
Deucravacitinib in PsA
Differences in Presentation and Outcomes of Early vs Late Onset PsA
Opioids and Health Care Utilization in PsA and AS
Patient Reported Outcomes in PsA Using Novel IL 17A Inhibitor
PsA Cycling or Switching MOAs
The Dietary Intervention in PsA (DIPSA) Study
Ultrasound in PsA
Upadacitinib vs Adalimumab in PsA using RAPID3

Sunday (Day 2): ACR 22 Daily Recap

Bouncebackability portends increased risk of adverse outcomes in RA
Can I stop Methotrexate in RA?
Fat and bone are never alone: osteoporotic fracture in RA
JAK inhibitors in rheumatic diseases
RA: Steroids are bad, again
Reproductive health in a post-Roe world
Sensor-engineered glove evaluates hand function in RA
Tapering Methotrexate with Biologics or JAK Inhibitors in RA
Tofacitinib and RA-ILD

ACR22 Daily Recap: Saturday Recap
JAK vs TNF inhibitor Infections in RA
Opioid and Neuropathic Use After Initiating btsDMARDs in RA
Pre-RA Pharmacological Interventions: Delaying is not Enough
PreRA to Treat or Not!
Prescribing Methotrexate in Post-Roe Era
The Great Debate: To Treat or Not to Treat Pre RA
To Switch or Not: Biosimilars in Inflammatory Arthritis

ACR22 Year in Review Report
Can computers tell the difference between RA & PsA?
NSAIDs and CV risk in Inflammatory Arthritis
Prelude to a Meeting (ACR22) (11.11.2022)
QD205 - RA Activity During Pregnancy (abstract #0955)
Sputum anti-CCP the new diagnostic test in at-risk RA?
Switching Between JAK Inhibiters in RA
Treatment Choices and Mortality in RA ILd

Treatment Considerations in Axial Spondyloarthritis
What Happens after you stop biologics?
What lifestyle factors affect TNF inhibitor efficacy in AxSpA?
Which is better for AxSpA? IL-17i or TNFi?
Women vs. Men: Response to Treatment in Seronegative Arthritis

Opioids and Health Care Utilization in PsA and AS
Reproductive health in a post-Roe world
Spondyloarthritis: Novel Therapies, Diagnostic Dilemmas and Depression
Sunday (Day 2): ACR 22 Daily Recap
Tapering TNFi in nonradiographic AxSpA
The CONSUL Trial: Ankylosing Spondylitis